Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Lacosamide Tablets market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
50 mg/tablet Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Lacosamide Tablets include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories, Alembic Pharma, Glenmark, Accord Healthcare, Mylan and Sun PharmaApotex, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ("complementary therapy") to treat focal seizures (seizures that start in one area of the brain).
This report aims to provide a comprehensive presentation of the global market for Lacosamide Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lacosamide Tablets. This report contains market size and forecasts of Lacosamide Tablets in global, including the following market information:
Global Lacosamide Tablets Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Lacosamide Tablets Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Lacosamide Tablets companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Lacosamide Tablets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lacosamide Tablets Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lacosamide Tablets Market Segment Percentages, by Type, 2022 (%)
50 mg/tablet
100 mg/tablet
150 mg/tablet
200 mg/tablet
Global Lacosamide Tablets Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lacosamide Tablets Market Segment Percentages, by Application, 2022 (%)
Adults
Children
Global Lacosamide Tablets Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Lacosamide Tablets Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lacosamide Tablets revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Lacosamide Tablets revenues share in global market, 2022 (%)
Key companies Lacosamide Tablets sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Lacosamide Tablets sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
UCB
Aesica Pharmaceuticals GmbH
Teva
MSN Laboratories
Alembic Pharma
Glenmark
Accord Healthcare
Mylan
Sun PharmaApotex
Jiangxi Qingfeng Pharmaceutical
Beijing Sihuan Pharmaceutical
Buchang Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Lacosamide Tablets, market overview.
Chapter 2: Global Lacosamide Tablets market size in revenue and volume.
Chapter 3: Detailed analysis of Lacosamide Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Lacosamide Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Lacosamide Tablets capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Lacosamide Tablets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Lacosamide Tablets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Lacosamide Tablets Overall Market Size
2.1 Global Lacosamide Tablets Market Size: 2022 VS 2029
2.2 Global Lacosamide Tablets Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Lacosamide Tablets Sales: 2018-2029
3 Company Landscape
3.1 Top Lacosamide Tablets Players in Global Market
3.2 Top Global Lacosamide Tablets Companies Ranked by Revenue
3.3 Global Lacosamide Tablets Revenue by Companies
3.4 Global Lacosamide Tablets Sales by Companies
3.5 Global Lacosamide Tablets Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Lacosamide Tablets Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Lacosamide Tablets Product Type
3.8 Tier 1, Tier 2 and Tier 3 Lacosamide Tablets Players in Global Market
3.8.1 List of Global Tier 1 Lacosamide Tablets Companies
3.8.2 List of Global Tier 2 and Tier 3 Lacosamide Tablets Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Lacosamide Tablets Market Size Markets, 2022 & 2029
4.1.2 50 mg/tablet
4.1.3 100 mg/tablet
4.1.4 150 mg/tablet
4.1.5 200 mg/tablet
4.2 By Type - Global Lacosamide Tablets Revenue & Forecasts
4.2.1 By Type - Global Lacosamide Tablets Revenue, 2018-2023
4.2.2 By Type - Global Lacosamide Tablets Revenue, 2024-2029
4.2.3 By Type - Global Lacosamide Tablets Revenue Market Share, 2018-2029
4.3 By Type - Global Lacosamide Tablets Sales & Forecasts
4.3.1 By Type - Global Lacosamide Tablets Sales, 2018-2023
4.3.2 By Type - Global Lacosamide Tablets Sales, 2024-2029
4.3.3 By Type - Global Lacosamide Tablets Sales Market Share, 2018-2029
4.4 By Type - Global Lacosamide Tablets Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Lacosamide Tablets Market Size, 2022 & 2029
5.1.2 Adults
5.1.3 Children
5.2 By Application - Global Lacosamide Tablets Revenue & Forecasts
5.2.1 By Application - Global Lacosamide Tablets Revenue, 2018-2023
5.2.2 By Application - Global Lacosamide Tablets Revenue, 2024-2029
5.2.3 By Application - Global Lacosamide Tablets Revenue Market Share, 2018-2029
5.3 By Application - Global Lacosamide Tablets Sales & Forecasts
5.3.1 By Application - Global Lacosamide Tablets Sales, 2018-2023
5.3.2 By Application - Global Lacosamide Tablets Sales, 2024-2029
5.3.3 By Application - Global Lacosamide Tablets Sales Market Share, 2018-2029
5.4 By Application - Global Lacosamide Tablets Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Lacosamide Tablets Market Size, 2022 & 2029
6.2 By Region - Global Lacosamide Tablets Revenue & Forecasts
6.2.1 By Region - Global Lacosamide Tablets Revenue, 2018-2023
6.2.2 By Region - Global Lacosamide Tablets Revenue, 2024-2029
6.2.3 By Region - Global Lacosamide Tablets Revenue Market Share, 2018-2029
6.3 By Region - Global Lacosamide Tablets Sales & Forecasts
6.3.1 By Region - Global Lacosamide Tablets Sales, 2018-2023
6.3.2 By Region - Global Lacosamide Tablets Sales, 2024-2029
6.3.3 By Region - Global Lacosamide Tablets Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Lacosamide Tablets Revenue, 2018-2029
6.4.2 By Country - North America Lacosamide Tablets Sales, 2018-2029
6.4.3 US Lacosamide Tablets Market Size, 2018-2029
6.4.4 Canada Lacosamide Tablets Market Size, 2018-2029
6.4.5 Mexico Lacosamide Tablets Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Lacosamide Tablets Revenue, 2018-2029
6.5.2 By Country - Europe Lacosamide Tablets Sales, 2018-2029
6.5.3 Germany Lacosamide Tablets Market Size, 2018-2029
6.5.4 France Lacosamide Tablets Market Size, 2018-2029
6.5.5 U.K. Lacosamide Tablets Market Size, 2018-2029
6.5.6 Italy Lacosamide Tablets Market Size, 2018-2029
6.5.7 Russia Lacosamide Tablets Market Size, 2018-2029
6.5.8 Nordic Countries Lacosamide Tablets Market Size, 2018-2029
6.5.9 Benelux Lacosamide Tablets Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Lacosamide Tablets Revenue, 2018-2029
6.6.2 By Region - Asia Lacosamide Tablets Sales, 2018-2029
6.6.3 China Lacosamide Tablets Market Size, 2018-2029
6.6.4 Japan Lacosamide Tablets Market Size, 2018-2029
6.6.5 South Korea Lacosamide Tablets Market Size, 2018-2029
6.6.6 Southeast Asia Lacosamide Tablets Market Size, 2018-2029
6.6.7 India Lacosamide Tablets Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Lacosamide Tablets Revenue, 2018-2029
6.7.2 By Country - South America Lacosamide Tablets Sales, 2018-2029
6.7.3 Brazil Lacosamide Tablets Market Size, 2018-2029
6.7.4 Argentina Lacosamide Tablets Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Lacosamide Tablets Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Lacosamide Tablets Sales, 2018-2029
6.8.3 Turkey Lacosamide Tablets Market Size, 2018-2029
6.8.4 Israel Lacosamide Tablets Market Size, 2018-2029
6.8.5 Saudi Arabia Lacosamide Tablets Market Size, 2018-2029
6.8.6 UAE Lacosamide Tablets Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 UCB
7.1.1 UCB Company Summary
7.1.2 UCB Business Overview
7.1.3 UCB Lacosamide Tablets Major Product Offerings
7.1.4 UCB Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.1.5 UCB Key News & Latest Developments
7.2 Aesica Pharmaceuticals GmbH
7.2.1 Aesica Pharmaceuticals GmbH Company Summary
7.2.2 Aesica Pharmaceuticals GmbH Business Overview
7.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Major Product Offerings
7.2.4 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.2.5 Aesica Pharmaceuticals GmbH Key News & Latest Developments
7.3 Teva
7.3.1 Teva Company Summary
7.3.2 Teva Business Overview
7.3.3 Teva Lacosamide Tablets Major Product Offerings
7.3.4 Teva Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.3.5 Teva Key News & Latest Developments
7.4 MSN Laboratories
7.4.1 MSN Laboratories Company Summary
7.4.2 MSN Laboratories Business Overview
7.4.3 MSN Laboratories Lacosamide Tablets Major Product Offerings
7.4.4 MSN Laboratories Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.4.5 MSN Laboratories Key News & Latest Developments
7.5 Alembic Pharma
7.5.1 Alembic Pharma Company Summary
7.5.2 Alembic Pharma Business Overview
7.5.3 Alembic Pharma Lacosamide Tablets Major Product Offerings
7.5.4 Alembic Pharma Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.5.5 Alembic Pharma Key News & Latest Developments
7.6 Glenmark
7.6.1 Glenmark Company Summary
7.6.2 Glenmark Business Overview
7.6.3 Glenmark Lacosamide Tablets Major Product Offerings
7.6.4 Glenmark Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.6.5 Glenmark Key News & Latest Developments
7.7 Accord Healthcare
7.7.1 Accord Healthcare Company Summary
7.7.2 Accord Healthcare Business Overview
7.7.3 Accord Healthcare Lacosamide Tablets Major Product Offerings
7.7.4 Accord Healthcare Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.7.5 Accord Healthcare Key News & Latest Developments
7.8 Mylan
7.8.1 Mylan Company Summary
7.8.2 Mylan Business Overview
7.8.3 Mylan Lacosamide Tablets Major Product Offerings
7.8.4 Mylan Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.8.5 Mylan Key News & Latest Developments
7.9 Sun PharmaApotex
7.9.1 Sun PharmaApotex Company Summary
7.9.2 Sun PharmaApotex Business Overview
7.9.3 Sun PharmaApotex Lacosamide Tablets Major Product Offerings
7.9.4 Sun PharmaApotex Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.9.5 Sun PharmaApotex Key News & Latest Developments
7.10 Jiangxi Qingfeng Pharmaceutical
7.10.1 Jiangxi Qingfeng Pharmaceutical Company Summary
7.10.2 Jiangxi Qingfeng Pharmaceutical Business Overview
7.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Major Product Offerings
7.10.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.10.5 Jiangxi Qingfeng Pharmaceutical Key News & Latest Developments
7.11 Beijing Sihuan Pharmaceutical
7.11.1 Beijing Sihuan Pharmaceutical Company Summary
7.11.2 Beijing Sihuan Pharmaceutical Lacosamide Tablets Business Overview
7.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Major Product Offerings
7.11.4 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.11.5 Beijing Sihuan Pharmaceutical Key News & Latest Developments
7.12 Buchang Pharmaceutical
7.12.1 Buchang Pharmaceutical Company Summary
7.12.2 Buchang Pharmaceutical Lacosamide Tablets Business Overview
7.12.3 Buchang Pharmaceutical Lacosamide Tablets Major Product Offerings
7.12.4 Buchang Pharmaceutical Lacosamide Tablets Sales and Revenue in Global (2018-2023)
7.12.5 Buchang Pharmaceutical Key News & Latest Developments
8 Global Lacosamide Tablets Production Capacity, Analysis
8.1 Global Lacosamide Tablets Production Capacity, 2018-2029
8.2 Lacosamide Tablets Production Capacity of Key Manufacturers in Global Market
8.3 Global Lacosamide Tablets Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Lacosamide Tablets Supply Chain Analysis
10.1 Lacosamide Tablets Industry Value Chain
10.2 Lacosamide Tablets Upstream Market
10.3 Lacosamide Tablets Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Lacosamide Tablets Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
